DD108760A1 - - Google Patents

Info

Publication number
DD108760A1
DD108760A1 DD17437373A DD17437373A DD108760A1 DD 108760 A1 DD108760 A1 DD 108760A1 DD 17437373 A DD17437373 A DD 17437373A DD 17437373 A DD17437373 A DD 17437373A DD 108760 A1 DD108760 A1 DD 108760A1
Authority
DD
German Democratic Republic
Application number
DD17437373A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to DD17437373A priority Critical patent/DD108760A1/xx
Publication of DD108760A1 publication Critical patent/DD108760A1/xx

Links

DD17437373A 1973-11-02 1973-11-02 DD108760A1 (ru)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DD17437373A DD108760A1 (ru) 1973-11-02 1973-11-02

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DD17437373A DD108760A1 (ru) 1973-11-02 1973-11-02

Publications (1)

Publication Number Publication Date
DD108760A1 true DD108760A1 (ru) 1974-10-05

Family

ID=5493286

Family Applications (1)

Application Number Title Priority Date Filing Date
DD17437373A DD108760A1 (ru) 1973-11-02 1973-11-02

Country Status (1)

Country Link
DD (1) DD108760A1 (ru)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1840145A1 (en) 2006-03-30 2007-10-03 GAT Microencapsulation AG Acetylene carbamide derivatives-polyurea polymers and microcapsules and formulations thereof for controlled release
WO2007112933A1 (en) * 2006-03-30 2007-10-11 Gat Microencapsulation Ag Reverse-phase microcapsules for active ingredients, simplified process of manufacture thereof and combined formulations wdg-cs, zc, ec-sc and cx

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1840145A1 (en) 2006-03-30 2007-10-03 GAT Microencapsulation AG Acetylene carbamide derivatives-polyurea polymers and microcapsules and formulations thereof for controlled release
WO2007112933A1 (en) * 2006-03-30 2007-10-11 Gat Microencapsulation Ag Reverse-phase microcapsules for active ingredients, simplified process of manufacture thereof and combined formulations wdg-cs, zc, ec-sc and cx
WO2007112934A1 (en) * 2006-03-30 2007-10-11 Gat Microencapsulation Ag Microcapsules with acetylene carbamide-polyurea polymers and formulations thereof for controlled release
US8216598B2 (en) 2006-03-30 2012-07-10 Gat Microencapsulation Ag Microcapsules with acetylene carbamide-polyurea polymers and formulations thereof for controlled release
EP2487192A3 (en) * 2006-03-30 2012-09-05 Gat Microencapsulation, AG Microencapsulation of clomazone by means of a refined process and specific microcapsules produced thereof
US8337900B2 (en) 2006-03-30 2012-12-25 Casanginer Victor Reverse-phase microcapsules for active ingredients, simplified process of manufacture thereof and combined formulation WDG-CS, ZC, EC-SC, and CX
EP1840145B1 (en) 2006-03-30 2017-11-08 FMC Corporation Acetylene carbamide derivatives-polyurea polymers and microcapsules and formulations thereof for controlled release
EP2487192B1 (en) 2006-03-30 2021-03-03 FMC Corporation Microencapsulation of clomazone by means of a refined process and specific microcapsules produced thereof

Similar Documents

Publication Publication Date Title
AR201758A1 (ru)
AU476761B2 (ru)
AU465372B2 (ru)
AU474593B2 (ru)
AU474511B2 (ru)
AU474838B2 (ru)
AU465453B2 (ru)
AU465434B2 (ru)
AU471343B2 (ru)
AU450229B2 (ru)
AU476714B2 (ru)
AU476696B2 (ru)
AU466283B2 (ru)
AU472848B2 (ru)
AU477823B2 (ru)
AR196382A1 (ru)
AR210729A1 (ru)
AU447540B2 (ru)
AU461342B2 (ru)
AU476873B1 (ru)
AU471461B2 (ru)
AU477824B2 (ru)
AU1891376A (ru)
BG21371A3 (ru)
BG19243A1 (ru)